These frequencies suggest that universal MMR deficiency testing of all Lynch-spectrum tumours would have an equivalent sensitivity for LS detection as MMR deficiency testing of CRCs and ECs. The gene discussed is MRC1; the disease is hyperinsulinemic hypoglycemia, familial, 4.